IsoRay Medical, Inc.'s Cesium-131 Cancer Therapy Technology Receives R&D100 Award

July 10, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RICHLAND, Wash.--(BUSINESS WIRE)--July 10, 2006--IsoRay Medical, Inc.'s (OTCBB:ISRY - News) patented Cesium-131 brachytherapy seed (TM) technology has been named one of the year's 100 most technologically significant products by R&D Magazine.

Twitter
LinkedIn
Facebook
Email
Print